Imprimis offshoot raises $20M to develop dry-eye meds
FierceBiotech-22 hours ago
RELATED: Imprimis spins out dry eye disease drugs to create biotech. Imprimis has a history of identifying compounded drugs it believes can win their own FDA ...
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
No comments:
Post a Comment